COMPANY ALSO ANNOUNCES CHAIR, PRESIDENT AND CEO SHELLY IBACH TO RETIRE

Reported third quarter net sales of $427 million; delivered adjusted EBITDA of $28 million for the quarter which was consistent with expectations
Achieved gross margin rate of 60.8% for the third quarter, up 340 basis points versus last year, ahead of expectations and the highest quarterly gross margin rate since the third quarter of 2021
Reduced operating expenses by $17 million for the third quarter and $60 million year-to-date (before restructuring costs)
Increased year-to-date free cash flow by $50 million compared with the same period last year
Updated full-year 2024 adjusted EBITDA outlook to a revised range of $115 million to $125 million

Sleep Number Corporation (NASDAQ:SNBR) today reported results for the quarter ended September 28, 2024.

"Our actions throughout the business over the past year are driving sustainable operating model improvements and contributing to our increased financial flexibility and durability. Our initiatives drove broad cost efficiencies and a gross margin rate improvement to 60.8%, resulting in third quarter adjusted EBITDA of $28 million, which was in-line with expectations even with persistent consumer demand weakness," said Shelly Ibach, Chair, President and CEO. "At the same time, we continue to leverage our innovation superiority to provide customers with life-changing sleep solutions, like our new ClimateCool™ smart bed."

"Throughout my tenure, I have been inspired by our team's commitment to our purpose, beloved brand, and pioneering smart beds that deliver proven quality sleep," added Ibach. "As I transition to retirement, our talented team and strong competitive advantages, combined with our increased financial resilience, give me confidence in Sleep Number's continued market leadership and its ability to accelerate profitable growth and value creation for all stakeholders when industry demand recovers."

Third Quarter Overview

Net sales of $427 million were down 10% versus the prior year, including approximately two percentage points of pressure from year-over-year order backlog changes and one-point of pressure from lower store count versus the prior year
Gross margin of 60.8% was up 340 basis points versus the prior year, driven by year-over-year product cost reductions through value engineering and ongoing supplier negotiations, favorable product mix, and efficiency gains in our home delivery and logistics operations
Operating expenses of $249 million (before restructuring charges) were down $17 million versus the prior year's third quarter, with year-to-date operating expenses down $60 million (before restructuring charges)
Adjusted EBITDA of $28 million was up 11% compared to the prior year, with an adjusted EBITDA margin of 6.5%, up 120 bp versus the prior year

Cash Flow Review

Net cash provided by operating activities of $51 million for the first nine months of the year, up $19 million, or 60%, versus the same period last year
Free cash flow of $34 million for the first nine months of the year, up $50 million versus the same period last year
Leverage ratio of 4.2x EBITDAR at the end of the third quarter versus covenant maximum of 5.0x for the quarter

Financial Outlook

With ongoing weakness in the bedding industry, the company has updated its full-year 2024 adjusted EBITDA outlook to a revised range of $115 million to $125 million. The company expects 2024 full-year net sales to be down approximately 10%, consistent with year-to-date net sales performance. The company's outlook includes at least 150 basis points of gross margin rate improvement for the year. The company expects to generate $10 million to $20 million of free cash flow for the year with capital expenditures of approximately $25 million.

CEO Retirement and Board and Governance Changes

In a separate release today, the company announced the following:

Ibach to retire no later than the 2025 Annual Meeting of Shareholders (the "2025 Annual Meeting"), following a comprehensive search to identify her successor conducted by an independent executive search firm
Ibach will not stand for reelection to the Board at the 2025 Annual Meeting, at which time, the Board intends to appoint Michael J. Harrison as independent Chair of the Board
The Board intends to reduce its size, with two longer serving directors to retire at or before the 2026 Annual Meeting
The Board intends to amend the company's governing documents, requesting shareholder approval at the 2025 Annual Meeting to begin a process to declassify the Board and adopt a majority voting standard for approval of mergers and amendments to the company's Articles of Incorporation

The full announcement is available here: https://www.businesswire.com/news/home/54144842/en

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company's results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. We have also posted an updated investor presentation to the investor relations area of the Sleep Number website.

About Sleep Number Corporation

Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved nearly 16 million lives. Our wellness technology platform helps solve sleep problems, whether it's providing individualized temperature control for each sleeper through our Climate360^® smart bed or applying our more than 29 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our 3,700 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in nearly 650 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number^® store near you, our newsroom and investor relations sites, or SleepNumber.com

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance, such as the statements that the company is driving sustainable operating model improvements and contributing to its increased financial flexibility and durability, continues to leverage its innovation superiority to provide customers with life-changing sleep solutions, and is positioned for continued market leadership and to accelerate profitable growth and value creation for all stakeholders when demand recovers; statements about the company's financial outlook, including the company's expected 2024 adjusted EBITDA and future net sales, demand, gross margin, and free cash flow expectations; and statements about its CEO and Board retirements and governance changes are forward-looking statements subject to certain risks and uncertainties which could cause the company's results to differ materially. The most important risks and uncertainties are described in the company's filings with the Securities and Exchange Commission, including in Item 1A of the company's Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Consolidated Statements of Operations* (unaudited – in thousands, except per share amounts)

	Three Months Ended
	September 28, 2024			% of Net Sales		September 30, 2023			% of Net Sales
Net sales	$	426,617		100.0	%	$	472,648		100.0	%
Cost of sales		167,089		39.2	%		201,537		42.6	%
Gross profit		259,528		60.8	%		271,111		57.4	%
Operating expenses:
Sales and marketing		205,480		48.2	%		221,143		46.8	%
General and administrative		33,070		7.8	%		31,948		6.8	%
Research and development		10,583		2.5	%		12,633		2.7	%
Restructuring costs		1,963		0.5	%		—		0.0	%
Total operating expenses		251,096		58.9	%		265,724		56.2	%
Operating income		8,432		2.0	%		5,387		1.1	%
Interest expense, net		12,057		2.8	%		10,958		2.3	%
Loss before income taxes		(3,625	)	(0.8	%)		(5,571	)	(1.2	%)
Income tax benefit		(489	)	(0.1	%)		(3,253	)	(0.7	%)
Net loss	$	(3,136	)	(0.7	%)	$	(2,318	)	(0.5	%)

Net loss per share – basic	$	(0.14	)			$	(0.10	)

Net loss per share – diluted	$	(0.14	)			$	(0.10	)

Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding		22,643					22,479
Dilutive effect of stock-based awards		—					—
Diluted weighted-average shares outstanding		22,643					22,479

For the three months ended September 28, 2024 and September 30,2023, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Consolidated Statements of Operations* (unaudited – in thousands, except per share amounts)

	Nine Months Ended
	September 28, 2024			% of Net Sales		September 30, 2023		% of Net Sales
Net sales	$	1,305,479		100.0	%	$	1,457,964	100.0	%
Cost of sales		528,287		40.5	%		612,343	42.0	%
Gross profit		777,192		59.5	%		845,621	58.0	%
Operating expenses:
Sales and marketing		596,392		45.7	%		649,410	44.5	%
General and administrative		111,722		8.6	%		111,144	7.6	%
Research and development		34,602		2.7	%		42,521	2.9	%
Restructuring costs		14,382		1.1	%		—	0.0	%
Total operating expenses		757,098		58.0	%		803,075	55.1	%
Operating income		20,094		1.5	%		42,546	2.9	%
Interest expense, net		36,626		2.8	%		30,008	2.1	%
(Loss) income before income taxes		(16,532	)	(1.3	%)		12,538	0.9	%
Income tax (benefit) expense		(863	)	(0.1	%)		2,637	0.2	%
Net (loss) income	$	(15,669	)	(1.2	%)	$	9,901	0.7	%

Net (loss) income per share – basic	$	(0.69	)			$	0.44

Net (loss) income per share – diluted	$	(0.69	)			$	0.44

Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding		22,588					22,412
Dilutive effect of stock-based awards		—					146
Diluted weighted-average shares outstanding		22,588					22,558

For the nine months ended September 28, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Consolidated Balance Sheets* (unaudited – in thousands, except per share amounts) subject to reclassification

	September 28, 2024			December 30, 2023
Assets
Current assets:
Cash and cash equivalents	$	1,592		$	2,539
Accounts receivable, net of allowances of $1,134 and $1,437, respectively		17,026			26,859
Inventories		93,039			115,433
Prepaid expenses		17,827			16,660
Other current assets		40,784			44,637
Total current assets		170,268			206,128
Non-current assets:
Property and equipment, net		140,406			179,503
Operating lease right-of-use assets		367,133			395,411
Goodwill and intangible assets, net		66,468			66,634
Deferred income taxes		27,267			20,253
Other non-current assets		93,109			82,951
Total assets	$	864,651		$	950,880
Liabilities and Shareholders' Deficit
Current liabilities:
Borrowings under revolving credit facility	$	516,500		$	539,500
Accounts payable		127,990			135,901
Customer prepayments		43,514			49,143
Accrued sales returns		19,688			22,402
Compensation and benefits		28,909			28,273
Taxes and withholding		17,685			17,134
Operating lease liabilities		82,488			81,760
Other current liabilities		57,268			61,958
Total current liabilities		894,042			936,071
Non-current liabilities:
Operating lease liabilities		318,665			351,394
Other non-current liabilities		100,728			105,343
Total non-current liabilities		419,393			456,737
Total liabilities		1,313,435			1,392,808
Shareholders' deficit:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding		—			—
Common stock, $0.01 par value; 142,500 shares authorized, 22,371 and 22,235 shares issued and outstanding, respectively		224			222
Additional paid-in capital		25,527			16,716
Accumulated deficit		(474,535	)		(458,866	)
Total shareholders' deficit		(448,784	)		(441,928	)
Total liabilities and shareholders' deficit	$	864,651		$	950,880


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Consolidated Statements of Cash Flows* (unaudited – in thousands) subject to reclassification

	Nine Months Ended
	September 28, 2024			September 30, 2023
Cash flows from operating activities:
Net (loss) income	$	(15,669	)	$	9,901
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization		50,379			55,196
Stock-based compensation		9,541			10,872
Net loss on disposals and impairments of assets		2,457			464
Deferred income taxes		(7,014	)		(13,433	)
Changes in operating assets and liabilities:
Accounts receivable		9,833			7,374
Inventories		22,394			(2,190	)
Income taxes		1,708			3,571
Prepaid expenses and other assets		(8,012	)		(5,903	)
Accounts payable		4,980			5,199
Customer prepayments		(5,629	)		(27,279	)
Accrued compensation and benefits		788			(6,923	)
Other taxes and withholding		(1,157	)		5
Other accruals and liabilities		(13,775	)		(5,038	)
Net cash provided by operating activities		50,824			31,816

Cash flows from investing activities:
Purchases of property and equipment		(17,218	)		(48,022	)
Proceeds from sales of property and equipment		156			10
Issuance of notes receivable		(2,942	)		(1,317	)
Net cash used in investing activities		(20,004	)		(49,329	)

Cash flows from financing activities:
Net (decrease) increase in short-term borrowings		(31,039	)		20,334
Repurchases of common stock		(728	)		(3,711	)
Proceeds from issuance of common stock		—			428
Net cash (used in) provided by financing activities		(31,767	)		16,627

Net decrease in cash and cash equivalents		(947	)		(886	)
Cash and cash equivalents, at beginning of period		2,539			1,792
Cash and cash equivalents, at end of period	$	1,592		$	906


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Supplemental Financial Information* (unaudited)

	Three Months Ended						Nine Months Ended
	September 28, 2024			September 30, 2023			September 28, 2024			September 30, 2023
Percent of sales:
Retail stores		87.8	%		86.6	%		87.9	%		87.1	%
Online, phone, chat and other		12.2	%		13.4	%		12.1	%		12.9	%
Total Company		100.0	%		100.0	%		100.0	%		100.0	%

Sales change rates:
Retail comparable-store sales		(7	%)		(14	%)		(9	%)		(11	%)
Online, phone and chat		(18	%)		(14	%)		(17	%)		(13	%)
Total Retail comparable sales change		(9	%)		(14	%)		(10	%)		(11	%)
Net opened/closed stores and other		(1	%)		1	%		0	%		1	%
Total Company		(10	%)		(13	%)		(10	%)		(10	%)

Stores open:
Beginning of period		646			672			672			670
Opened		1			8			11			27
Closed		(4	)		(2	)		(40	)		(19	)
End of period		643			678			643			678

Other metrics:
Average sales per store ($ in 000's) ¹	$	2,670		$	2,952
Average sales per square foot ¹	$	863		$	963
Stores > $2 million net sales ²		60	%		67	%
Stores > $3 million net sales ²		20	%		27	%
Average revenue per smart bed unit ³	$	5,771		$	5,640		$	5,778		$	5,822

¹		Trailing twelve months Total Retail comparable sales per store open at least one year.
²		Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).
³		Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)* (in thousands)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation, restructuring costs and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

	Three Months Ended						Trailing Twelve Months Ended
	September 28, 2024			September 30, 2023			September 28, 2024			September 30, 2023
Net (loss) income	$	(3,136	)	$	(2,318	)	$	(40,857	)	$	4,471
Income tax (benefit) expense		(489	)		(3,253	)		(7,966	)		1,346
Interest expense		12,057			10,958			49,313			37,641
Depreciation and amortization		15,859			18,200			67,335			72,338
Stock-based compensation		1,432			982			13,523			15,511
Restructuring costs ¹		1,963			—			30,110			—
Asset impairments		—			292			198			491
Adjusted EBITDA	$	27,686		$	24,861		$	111,656		$	131,798

Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.

*Free Cash Flow* (in thousands)

	Nine Months Ended					Trailing Twelve Months Ended
	September 28, 2024		September 30, 2023			September 28, 2024			September 30, 2023
Net cash provided by (used in) operating activities	$	50,824	$	31,816		$	9,980		$	(12,168	)
Subtract: Purchases of property and equipment		17,218		48,022			26,252			64,668
Free cash flow	$	33,606	$	(16,206	)	$	(16,272	)	$	(76,836	)

Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. GAAP - generally accepted accounting principles in the U.S.


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Calculation of Net Leverage Ratio under Revolving Credit Facility* (in thousands)

Our calculation of Net Leverage Ratio under Revolving Credit Facility was changed effective with the amendment of our credit facility on November 2, 2023. Prior to the amendment, the calculation included capitalized operating lease obligations based on a multiple of six times annual rent expense. The amendment replaced this line item with operating lease liabilities included in our financial statements under ASC 842. The calculations in accordance with the November 2, 2023 amendment are presented below. The prior year is presented in conformity with the November 2, 2023 amendment.

	Trailing Twelve Months Ended
	September 28, 2024		September 30, 2023
Borrowings under revolving credit facility	$	516,500	$	488,000
Outstanding letters of credit		7,147		7,147
Finance lease obligations		261		338
Consolidated funded indebtedness	$	523,908	$	495,485
Operating lease liabilities ¹		401,153		439,722
Total debt including operating lease liabilities (a)	$	925,061	$	935,207

Adjusted EBITDA (see above)	$	111,656	$	131,798
Consolidated rent expense		108,863		113,204
Consolidated EBITDAR (b)	$	220,519	$	245,002
Net Leverage Ratio under revolving credit facility (a divided by b)	4.2 to 1.0		3.8 to 1.0

¹		Reflects operating lease liabilities included in our financial statements under ASC 842. The prior period has been updated to reflect this calculation.

Note - Our Net Leverage Ratio under Revolving Credit Facility, Adjusted EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Calculation of Return on Invested Capital (Adjusted ROIC)* (in thousands)

Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

	Trailing Twelve Months Ended
	September 28, 2024			September 30, 2023
Adjusted net operating profit after taxes (Adjusted NOPAT)
Operating income	$	490		$	43,458
Add: Operating lease interest ¹		27,371			27,497
Less: Income taxes ²		(5,474	)		(1,168	)
Adjusted NOPAT	$	22,387		$	69,787

Average adjusted invested capital
Total deficit	$	(448,784	)	$	(420,687	)
Add: Long-term debt ³		516,761			488,338
Add: Operating lease liabilities ⁴		401,153			439,722
Total adjusted invested capital at end of period	$	469,130		$	507,373

Average adjusted invested capital ⁵	$	502,494		$	469,782

Adjusted ROIC ⁶		4.5	%		14.9	%

¹		Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.
²		Reflects annual effective income tax rates, before discrete adjustments, of 19.6% and 1.6% for September 28, 2024 and September 30, 2023, respectively.
³		Long-term debt includes existing finance lease liabilities.
⁴		Reflects operating lease liabilities included in our financial statements under ASC 842.
⁵		Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.
⁶		Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

Note - The Company's Adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842.

GAAP - generally accepted accounting principles in the U.S.


SLEEP NUMBER CORPORATION AND SUBSIDIARIES *Reported to Adjusted Statements of Operations Data Reconciliation* (in thousands, except per share amounts)

	Three Months Ended
	September 28, 2024								September 30, 2023
	As Reported			Restructuring Costs ^1,2		As Adjusted			As Reported
Operating income	$	8,432		$	1,963	$	10,395		$	5,387
Interest expense, net		12,057			—		12,057			10,958
Loss before income taxes		(3,625	)		1,963		(1,662	)		(5,571	)
Income tax (benefit) expense		(489	)		465		(24	)		(3,253	)
Net loss	$	(3,136	)	$	1,498	$	(1,638	)	$	(2,318	)

Net (loss) income per share:
Basic	$	(0.14	)	$	0.07	$	(0.07	)	$	(0.10	)
Diluted	$	(0.14	)	$	0.07	$	(0.07	)	$	(0.10	)

Basic Shares		22,643			22,643		22,643			22,479
Diluted Shares		22,643			22,643		22,643			22,479

	Nine Months Ended
	September 28, 2024								September 30, 2023
	As Reported			Restructuring Costs ^1,2		As Adjusted			As Reported
Operating income	$	20,094		$	14,382	$	34,476		$	42,546
Interest expense, net		36,626			—		36,626			30,008
(Loss) income before income taxes		(16,532	)		14,382		(2,150	)		12,538
Income tax (benefit) expense		(863	)		3,409		2,546			2,637
Net (loss) income	$	(15,669	)	$	10,973	$	(4,696	)	$	9,901

Net (loss) income per share:
Basic	$	(0.69	)	$	0.49	$	(0.20	)	$	0.44
Diluted	$	(0.69	)	$	0.49	$	(0.20	)	$	0.44

Basic Shares		22,588			22,588		22,588			22,412
Diluted Shares		22,588			22,588		22,588			22,558

¹		Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.
²		The income tax expense is calculated using the estimated U.S. federal and state statutory tax rate of 23.7%.

Note - Our "as adjusted" data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates year-over-year comparisons for investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241030658483/en/

Sleep Number Announces Third Quarter 2024 Results